Showing results (211-220 of 251) with videos related to

Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care SettingSarah B Doernberg, Lilian M Abbo, Steven D Burdette, et al.
Journal of the National Cancer Institute|November 6, 2019
HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis StatusJessie Torgersen, Michael J Kallan, Dena M Carbonari, et al.
Plos One|July 23, 2025
Magnetic resonance evaluation of three-dimensional liver fat fraction by hepatitis C status and associations with inflammatory cytokinesJessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.
BMJ Open|March 19, 2026
Postmarketing safety surveillance for GSK's AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety studySruthi Adimadhyam, Dominique Luyts, Driss Oraichi, et al.
Pharmacoepidemiology and Drug Safety|April 2, 2021
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel SystemNoelle M Cocoros, Candace C Fuller, Sruthi Adimadhyam, et al.
JAMA Network Open|December 14, 2022
Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus TreatmentLamia Y Haque, David A Fiellin, Janet P Tate, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2021
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesVincent Lo Re, Dena M Carbonari, Jerry Jacob, et al.
BMJ Open Diabetes Research & Care|September 8, 2017
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomesVincent Lo Re, Dena M Carbonari, M Elle Saine, et al.
Open Forum Infectious Diseases|August 19, 2015
Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patientsKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Pageof 26